glp 1 medicaid covers GLP-1 meds for obesity in just 13 states, analysis finds Pennsylvania Medicaid stopped covering GLP-1s

In cases of severe deficiency or malabsorption, its more effective to use a B12 injection

In the present post hoc analysis published in Diabetes Care , Klein and colleagues examined data on the 16 996 adults participating in four large randomised, double-blind, placebo-controlled clinical trials assessing the safety and efficacy of GLP-1 RAs: the LEADER trial of liraglutide, the STEP 2 and SUSTAIN 6 trials of subcutaneous semaglutide, and the PIONEER 6 trial of oral semaglutide

Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice

Two reasons in the documented cadence